GENERAL NEWSHEALTH

Stop using oxytocin injection 10iu/ml; return them to our office – FDA warns health facilities

The Food and Drugs Authority (FDA) as part of its market surveillance activities has detected the presence of unregistered OXYTOCIN INJECTION 10iu/ml in hospitals, clinics and other health facilities across the country.

In a statement issued on Friday, 21 April 2023, signed by its Chief Executive Officer (CEO), the FDA, also gave details of the unregistered OXYTOCIN INJECTION 10iu/ml.

They include: “Beltocin,” manufactured by “Belco Pharma PVT Ltd” with India as the country of origin, “Oxytocin,” manufactured by “Entrance Pharmaceuticals” with the country of origin being Ghana, “Oxytocin,” manufactured by “AMROS Pharma” with Pakistan as the country of origin, “Oxytocin” manufactured by “Anhui Hongye Pharmaceutical Company Ltd” with China as the country of origin, “Oxytocin” manufactured by “Jackson Laboratories PVT Ltd,” manufactured in India.

“Oxytocin” manufactured by “Pharmanova Limited” with Ghana as the country of origin, Oxytocin manufactured by “Jiangsu Ruinian Quianjin Pharmaceutical Company Ltd” in China, “A-tocin” manufactured by “Health Care Pharma,” “Extocin” manufactured by “Anhui Hongye Pharmaceutical Company Ltd” with China as the country of origin, “Pitons” manufactured by Shanxi Shuguang Pharm. Company Ltd” also with China as the country of origin.

The others are: “Gold Vision” manufactured by Anhui Hongye Pharmaceutical Company Ltd with China as the origin, “Derm” manufactured by “Shandong Shenglu Pharmaceutical Company Ltd” with China as the origin.

According to the FDA, “these pharmaceutical products are not registered” and, therefore, their “quality, safety and efficacy cannot be ascertained.”

The FDA, therefore, informed all “health facilities and medical stores” of the mentioned “products to stop using them immediately and return them to the nearest FDA offices throughout the country.”

The FDA also assured the public that it is “liaising with importers to ensure that the market is rid of these unregistered pharmaceutical products.”

 

Source: classfmonline.com

Ogyem Solomon

Solomon Ogyem – Media Entrepreneur | Journalist | Brand Ambassador Solomon Ogyem is a dynamic Ghanaian journalist and media entrepreneur currently based in South Africa. With a solid foundation in journalism, Solomon is a graduate of the OTEC School of Journalism and Communication Studies in Ghana and Oxbridge Academy in South Africa. He began his career as a reporter at OTEC 102.9 MHz in Kumasi, where he honed his skills in news reporting, community storytelling, and radio broadcasting. His passion for storytelling and dedication to the media industry led him to establish Press MltiMedia Company in South Africa—a growing platform committed to authentic African narratives and multimedia journalism. Solomon is the founder and owner of Thepressradio.com, a news portal focused on delivering credible, timely, and engaging stories across Ghana and Africa. He also owns Press Global Tickets, a service-driven venture in the travel and logistics space, providing reliable ticketing services. In addition to his media ventures, Solomon serves as a Brand Ambassador for Alabuga, a prominent Russian industrial company, representing their interests and expansion across Africa. He previously owned two notable websites—Ghanaweb.mobi and ShowbizAfrica.net—both of which contributed to entertainment and socio-political discussions within Ghana’s digital space. With a diverse background in media, digital journalism, and business, Solomon Ogyem is dedicated to telling impactful African stories, empowering youth through media, and building cross-continental media partnerships.

Related Articles

Back to top button